PAP + Motivational Enhancement for Obstructive Sleep Apnea
(Champion Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you have unstable medical conditions or are using certain treatments for sleep apnea, you may not be eligible to participate.
What data supports the effectiveness of the treatment Motivational Enhancement Therapy (MET) for Obstructive Sleep Apnea?
Research shows that motivational interventions, like Motivational Enhancement Therapy (MET), can improve adherence to Positive Airway Pressure (PAP) therapy for Obstructive Sleep Apnea (OSA). Studies found that these interventions are more effective than usual care in helping patients stick to their CPAP treatment, although the benefits may not always last over time.12345
Is PAP therapy with motivational enhancement safe for humans?
How is the PAP + Motivational Enhancement treatment different from other treatments for obstructive sleep apnea?
The PAP + Motivational Enhancement treatment is unique because it combines Positive Airway Pressure (PAP) therapy with Motivational Enhancement Therapy (MET) to improve adherence. This approach uses motivational strategies to encourage patients to stick with their PAP therapy, which is often a challenge with standard treatments.23457
What is the purpose of this trial?
The purpose of this research is to compare the impact of motivational enhancement therapy (MET), delivered by culturally congruent community health care workers (CHWs) versus usual care patients with previously untreated moderate-to-severe obstructive sleep apnea (OSA) on adherence to positive airway pressure (PAP) therapy.
Research Team
Naresh Punjabi, MD
Principal Investigator
University of Miami
Eligibility Criteria
This trial is for adults over 18 with untreated moderate-to-severe obstructive sleep apnea who can attend study visits and have phone access. It's not for those with a history of OSA surgery, current PAP therapy users, commercial drivers, oxygen users during wakefulness or sleep, recent sleepy driving incidents, unstable medical conditions like uncontrolled heart issues or severe lung disease, active major psychiatric diseases, other sleep disorders, very low awake oxygen levels, insomnia sufferers or participants in another clinical trial.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either Motivational Enhancement Therapy (MET) with PAP therapy or standard PAP therapy
Follow-up
Participants are monitored for adherence to PAP therapy and secondary outcomes like glucose levels and blood pressure
Treatment Details
Interventions
- Motivational Enhancement Therapy
- Positive Airway Pressure (PAP) therapy
Motivational Enhancement Therapy is already approved in United States, European Union for the following indications:
- Alcohol Use Disorder
- Substance Abuse
- Intimate Partner Violence Prevention
- Alcohol Use Disorder
- Substance Abuse
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Miami
Lead Sponsor
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator